Imperva Target of Unusually High Options Trading (IMPV)

Imperva Inc (NASDAQ:IMPV) saw unusually large options trading activity on Wednesday. Stock investors purchased 582 put options on the stock. This represents an increase of 839% compared to the average volume of 62 put options.

Hedge funds have recently added to or reduced their stakes in the stock. Ameritas Investment Partners Inc. boosted its stake in Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after purchasing an additional 464 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Imperva in the 3rd quarter worth approximately $134,000. First Quadrant L P CA acquired a new stake in Imperva in the 3rd quarter worth approximately $136,000. Amalgamated Bank acquired a new stake in Imperva in the 2nd quarter worth approximately $206,000. Finally, Principal Financial Group Inc. acquired a new stake in Imperva in the 2nd quarter worth approximately $223,000. Institutional investors own 93.61% of the company’s stock.

Shares of Imperva (IMPV) opened at $46.00 on Thursday. Imperva has a 12 month low of $37.17 and a 12 month high of $52.40.

Imperva (NASDAQ:IMPV) last released its earnings results on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.13. The company had revenue of $91.10 million during the quarter, compared to analysts’ expectations of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. Imperva’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period last year, the business earned $0.32 EPS. analysts predict that Imperva will post -0.82 earnings per share for the current fiscal year.

A number of research firms have recently weighed in on IMPV. KeyCorp restated a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Oppenheimer restated a “buy” rating and issued a $55.00 price target on shares of Imperva in a report on Thursday, November 9th. Evercore ISI restated a “buy” rating and issued a $56.00 price target on shares of Imperva in a report on Wednesday, November 8th. Piper Jaffray Companies upgraded shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price target on the stock in a report on Friday, February 9th. Finally, JPMorgan Chase & Co. cut shares of Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 price target on the stock. in a report on Tuesday, December 12th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.93.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/15/imperva-target-of-unusually-high-options-trading-impv.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply